127 related articles for article (PubMed ID: 3107495)
21. [Treatment of hypertrophic obstructive cardiomyopathy with verapamil, a calcium antagonist (author's transl)].
Kaltenbach M; Hopf R; Keller M
Dtsch Med Wochenschr; 1976 Aug; 101(35):1284-7. PubMed ID: 8298
[TBL] [Abstract][Full Text] [Related]
22. The clinical and hemodynamic effects of propranolol, pindolol and verapamil in the treatment of exertional angina pectoris.
Johnston DL; Manyari DE; Kostuk WJ
Can Med Assoc J; 1984 Jun; 130(11):1449-55. PubMed ID: 6145515
[TBL] [Abstract][Full Text] [Related]
23. Use of calcium-channel blocking drugs in hypertrophic cardiomyopathy.
Rosing DR; Idänpään-Heikkilä U; Maron BJ; Bonow RO; Epstein SE
Am J Cardiol; 1985 Jan; 55(3):185B-195B. PubMed ID: 3881913
[TBL] [Abstract][Full Text] [Related]
24. [Risk of stress-induced ventricular arrhythmias in hypertrophic cardiomyopathy].
Lösse B; Christoph I; Borggrefe M; Königer HH
Z Kardiol; 1984 May; 73(5):304-12. PubMed ID: 6541405
[TBL] [Abstract][Full Text] [Related]
25. The effects of verapamil and propranolol on quality of life in hypertension.
Fletcher AE; Chester PC; Hawkins CM; Latham AN; Pike LA; Bulpitt CJ
J Hum Hypertens; 1989 Apr; 3(2):125-30. PubMed ID: 2668524
[TBL] [Abstract][Full Text] [Related]
26. [Hemodynamic effects of propranolol on obstructive myocardiopathy].
Ourbak P; Bourdarias JP; Cachin JC; Rocha P; Scebat L; Lenègre J
Arch Mal Coeur Vaiss; 1971 Mar; 64(3):352-71. PubMed ID: 4397007
[No Abstract] [Full Text] [Related]
27. [Long-term course of hypertrophic cardiomyopathy: drug versus surgical therapy].
Seiler C; Hess OM; Turina J; Schoenbeck M; Jenni R; Rothlin M; Senning A; Turina M; Krayenbühl HP
Schweiz Med Wochenschr; 1989 Oct; 119(43):1511-4. PubMed ID: 2609126
[TBL] [Abstract][Full Text] [Related]
28. [Effects of verapamil on systolic time intervals and relaxation time in hypertrophic cardiomyopathy (author's transl)].
Hirose K; Shimada T; Matsumura T; Iwata M; Yasunaga K; Hori K; Matsusaka J
J Cardiogr; 1981 Dec; 11(4):1223-32. PubMed ID: 7201494
[TBL] [Abstract][Full Text] [Related]
29. Influence of captopril, propranolol, and verapamil on arterial pulse wave velocity and other cardiovascular parameters in healthy volunteers.
Kähönen M; Ylitalo R; Kööbi T; Turjanmaa V; Ylitalo P
Int J Clin Pharmacol Ther; 1998 Sep; 36(9):483-9. PubMed ID: 9760009
[TBL] [Abstract][Full Text] [Related]
30. Hypertrophic occlusive cardiomyopathy.
Kaltenbach M; Hopf R
Clin Invest Med; 1980; 3(1-2):179-84. PubMed ID: 7008998
[No Abstract] [Full Text] [Related]
31. Use of verapamil in the treatment of hypertrophic cardiomyopathy.
Gregor P; Widimský P; Cervenka V; Vísek V; Sládková T; Dvorák J
Cor Vasa; 1986; 28(6):404-12. PubMed ID: 3829686
[TBL] [Abstract][Full Text] [Related]
32. [Importance of current ultrasonic study methods for the diagnosis, follow-up of treatment effectiveness and prognosis of patients with hypertrophic obstructive cardiomyopathy].
Pal L; Fedorova IF; Schäfer R; Sergakova LM; Naumov VG
Ter Arkh; 1987; 59(10):90-4. PubMed ID: 3433228
[TBL] [Abstract][Full Text] [Related]
33. A double-blind, placebo-controlled crossover trial of nadolol and verapamil in mild and moderately symptomatic hypertrophic cardiomyopathy.
Gilligan DM; Chan WL; Joshi J; Clarke P; Fletcher A; Krikler S; Oakley CM
J Am Coll Cardiol; 1993 Jun; 21(7):1672-9. PubMed ID: 8496536
[TBL] [Abstract][Full Text] [Related]
34. [Experience with the treatment of patients with hypertrophic cardiomyopathy with obsidan and isoptin].
Kisliak OA; Storozhakov GI
Kardiologiia; 1984 Aug; 24(8):27-30. PubMed ID: 6238196
[TBL] [Abstract][Full Text] [Related]
35. Propranolol versus verapamil for the treatment of essential hypertension.
Hornung RS; Jones RI; Gould BA; Sonecha T; Raftery EB
Am Heart J; 1984 Sep; 108(3 Pt 1):554-60. PubMed ID: 6382991
[TBL] [Abstract][Full Text] [Related]
36. Comparable effects of oral diltiazem and verapamil in the treatment of hypertrophic cardiomyopathy. Double-blind crossover study.
Toshima H; Koga Y; Nagata H; Toyomasu K; Itaya K; Matoba T
Jpn Heart J; 1986 Sep; 27(5):701-15. PubMed ID: 3546779
[TBL] [Abstract][Full Text] [Related]
37. Treatment of hypertrophic cardiomyopathy: relation to pathological mechanisms.
Kaltenbach M; Hopf R
J Mol Cell Cardiol; 1985 Jul; 17 Suppl 2():59-68. PubMed ID: 4040978
[TBL] [Abstract][Full Text] [Related]
38. Verapamil therapy: a new approach to pharmacologic treatment of hypertrophic cardiomyopathy.
Rosing DR; Kent KM; Maron BJ; Condit J; Epstein SE
Chest; 1980 Jul; 78(1 Suppl):239-47. PubMed ID: 6995039
[TBL] [Abstract][Full Text] [Related]
39. Exercise performance in hypertrophic cardiomyopathies.
Lösse B; Kuhn H; Loogen F; Schulte HD
Eur Heart J; 1983 Nov; 4 Suppl F():197-208. PubMed ID: 6686536
[TBL] [Abstract][Full Text] [Related]
40. [Acute effects of propranolol on the abnormal diastolic hemodynamics of the left ventricle in hypertrophic cardiomyopathy (author's transl)].
Koga Y; Akiyoski T; Nagae K; Mizobuchi H; Toshima H
Kokyu To Junkan; 1978 May; 26(5):473-6. PubMed ID: 351757
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
